-
Notitie 'Uitbreiding medische indicatie' toegelaten medicijnen (revisie) 12-03-2024 Notitie 'Uitbreiding medische indicatie' toegelaten medicijnen (revisie)PDF | 219,56 kB
-
-
Notitie 'Uitbreiding medische indicatie' toegelaten medicijnen 08-12-2023 Notitie 'Uitbreiding medische indicatie' toegelaten medicijnenDOCX | 54,01 kB
-
Good Practice on the assessment of GMO-related aspects in the context of clinical trials with human cells genetically modified by means of viral vectors v5 15-09-2023 Good Practice on the assessment of GMO-related aspects in the context of clinical trials with human cells genetically modified by means of viral vectors v5PDF | 471,66 kB
-
Common Application form for clinical research with human cells genetically modified by means of viral vectors v5 15-09-2023 Common Application form for clinical research with human cells genetically modified by means of viral vectors v5DOCX | 30,30 kB
-
Voorbeelden meldingscategorieën Rggo art35c 12-01-2023 Voorbeelden meldingscategorieën Rggo art35cPDF | 110,63 kB
-
Wijziging Regeling ggo 2013 tav meldingen klinische studies 12-01-2023 Wijziging Regeling ggo 2013 tav meldingen klinische studiesPDF | 1,47 MB
-
-
-
Gestandaardiseerde MRB VOV gm cellen AAV (art39d) 11-01-2023 Gestandaardiseerde MRB VOV gm cellen AAV (art39d)PDF | 598,01 kB